CVC-海外专场

CVC-海外专场Ⅰ

2022-09-13 19:00-21:00

• Biological conduits for the management of infected aortic prosthesis: The Attikon University Hospital experience

  Georgios Geroulakos  19:00-19:08

  Attikon University Hospital, Greece[专题报告]

• Transfemoral access in branched EVAR（to be determined）

  Tilo Kölbel  19:09-19:17

  University of Hamburg, Germany[专题报告]

• Historical note on endovascular technologies

  Jacques Busquet  19:18-19:26

  Clinique Chirurgicale Val d’Or, France[专题报告]

• Does inter-hospital transfer impact mortality in patients with ruptured abdominal aortic aneurysm

  Alexander Zimmermann  19:27-19:35

  University Hospital Zurich, Switzerland[专题报告]

• Polyester stent graft devices and higher risk of post-implantation syndrome after EVAR

  Arnaldo Ippoliti  19:36-19:44

  University of Rome "Tor Vergata", Italy[专题报告]

• Role of IVUS during BEVAR

  Michele Antonello  19:45-19:53

  Padua University Hospital, Italy [专题报告]

• Total endovascular management of type a aortic dissection: state of art 2022

  Antonio Rizza  19:54-20:02

  University of Pisa, Italy[专题报告]

• A new techniques of endovascular reconstruction of aortic bifurcation-CERAB

  Tomislav Krpan  20:03-20:11

  University Hospital Sestre Milosrdnice, Croatia[专题报告]

• Our experience with Lifetech Ankura abdominal aortic stent graft

  Nikola Kolev  20:12-20:20

  Military Medical Academy Sofia, Bulgaria[专题报告]

• Treatment of thoracic pathologies involving the aortic arch at level of the LSA with TEVAR using the Ankura graft and in-situ fenestration

  Marco Usai  20:21-20:29

  Franziskus Hospital Münster, Germany[专题报告]

• Discussion

    20:30-21:00

  [讨论]